← FDA Drug Approvals (Drugs@FDA)

OXYTROL FOR WOMEN

NDA · New Drug Application · Sponsor: ABBVIE · Approved 2013-01-25

Drug application

FDA Application #

NDA202211

Application type

New Drug Application

Brand name

OXYTROL FOR WOMEN

Generic name

OXYBUTYNIN

Active ingredients

OXYBUTYNIN

Dosage form

FILM, EXTENDED RELEASE

Route

TRANSDERMAL

Marketing status

Over-the-counter

Sponsor

ABBVIE

Manufacturer

Allergan, Inc.

First approval

2013-01-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown